RetailEnergyHealthcareHomebuilding & Real EstateAirlinesCryptoDefenseFood & BeverageEntertainment & MediaIndustrialsBanks & FinancePayment Services
Healthcare
Explore the latest market news on the healthcare industry, pharmaceuticals, biotech stock and distributors.
Last month
featured
From AI to Healthcare, Proprietary Data Reshapes Venture Investing
Healthcare Inflation Drives Demand for Purpose‑Built ETF Strategies
Financial Improvements v. Risks Ahead: Key Takeaways in UNH Earnings
Monday's Final Takeaways: LLY New Acquisition & AAL Shuts Down UAL Bid
WHD, SON, TIGO, and HRMY Highlight a Long‑Term Value Playbook
UnitedHealth's Earnings & Guidance Importance, UNH Options Trade
featured
Jay Woods Talks NVDA, NOW, UNH & Navigating Iran Volatility
The Big 3: PFE, V, SYF
Mackenzie Peterson on A.I. Buildout, Industrial Demand, and Biotech Momentum
JNJ Balances Growth, Patent Transitions, and Legal Overhangs
Tuesday's Morning Movers: ORCL & BE Extend Partnership, KMX & JNJ Earnings
LNG Bullish Options Trade Amid Strait of Hormuz Uncertainty, ELV Medicare Rate Lift
featured
Amy Zhang's Health Care Picks Amid Geopolitical Uncertainty
Tuesday's Final Takeaways: Healthcare, Chips, and Airlines in Focus as Markets Shift
GOOGL & MSFT 'Hidden Assets' & Markets Navigating 'Knife Edge'
LLY v. NVO: Weighing Who's Winning the GLP-1 Industry
Closing Bell: Growth and Staples Surge as Dow Theory Hands Bulls a Lifeline
AI Can’t Replace Caregivers: Healthcare Hiring Surges
MSFT, AVGO, LLY & Other Stock Market Opportunities Amid U.S.-Iran War
Oil Prices Making Dents in Economy, Consumer Sentiment
Closing Bell: Memory Leads Stocks Higher Ahead of Trump Speech
featured
Graham: Brace for 'V-Shape' Market Bottom, Likes COHR, LITE & ANET in AI Recovery
This year
NVO Stock 'Nothing Short of Disaster,' Wegovy Subscription Program Lifts Shares
Healthcare, GOOGL & PLTR Establish AI Software Strength in Tech Slowdown
Opportunities in Cybersecurity & Pharma After Software's SaaS-pocalypse
Dietze: Market Can Bounce Back from Iran Conflict, Likes KKR, TAP, UNH
The Big 3: ORCL, JNJ, SBUX
The Big 3: PR, ELF, SNY
Tuesday's Morning Movers: DAL Lifts Guidance, LLY & DKNG Downgrades
Chart of the Day: LLY Finds Support
HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s
Closing Bell: Markets Advance on Hopes Iran Conflict Will Be Short Lived
featured
Sansoterra: NVDA 'Number One' AI Play, PLTR 'Expensive' Cost Worth Price
Monday's Market Movers: CRWD Rallies, NVO Downgrade, BRK/B Earnings
featured
Elanco (ELAN) CEO on How Their ‘Big Six’ Blockbusters Can Double Over the Next Few Years
featured
Ethos IPO Signals a Digital Shift in Life Insurance
featured
Joe Maginot's Case Against NVDA & Finding New Market Opportunities
HIMS Core Business Faces Challenges in Guidance, GLP-1 Prices & NVO
KDP Beats & HIMS Misses Sales, QCOM Gains on Upgrades
featured
HIMS Headwinds Ahead of Earnings
Wednesday's Final Takeaways: MRNA Flu Vaccine & Oil Creeps Higher
MRNA Starts 2026 Volatile: Examining Rally & Pullback, Outsized Options
HIMS Slides Over 25% After NVO Sues Company Over Generic GLP-1 Pills
Friday's Earnings Movers: RBLX Rallies, MOH 'Shockingly Weak,' AFRM Beats
The Big 3: JNJ, XOM, KO
LLY Becomes 'Dominant' GLP-1 Winner, NVO Growth Turns Anemic
featured
Inside the ‘Drastic Understaffing’ in Healthcare & Patient Impact
Reasons Behind Bitcoin’s Collapse, Opportunities in Pharma
Closing Bell: Tech Slide Deepens and Geopolitical Tensions Fuel Volatility
LLY Gains on NVO Losses & Outlook for Weight Loss Drug Trade
featured
ENPH Earnings Power Rally, LLY Gains on GLP-1s, CMG Slides
featured
'Goldilocks' Theme in Today's Markets
Older
Moser: Small Cap Outperformance in 2026, Likes Biotech Including PCRX, SIBN
Growth Drivers Changing into 2026, but Double Digit Returns Possible
featured
David Dietze’s Stock Picks for the New Year: FISV, DEO, UNH
The Big 3: JNJ, SNDK, TWLO
Tuesday's Final Takeaways: Gold/Silver High, Weight Loss Pill Approved, Bitcoin Pulls Back
featured
'Very Optimistic' on Broader Market in 2026
featured
Testing Testosterone Using AI
Landsberg’s ‘Cheap’ Picks for 2026: VIK, URBN, ARGX
Wednesday's Final Takeaways: MDLN Surges Post-IPO & LEN Slumps Post-Earnings
featured
Ted Weisberg on 'Intelligent Investing,' Finding Value in 'Lumps of Coal' Stocks
featured
LLY Leading Weight Loss Trade, Hold Economic 'Trickle Down Effect'
Halter’s Healthcare & Energy Picks: SYK, UNH, SO, NEE & More
Thursday's Final Takeaways: LLY Positive Drug Trial, Home Prices Turn Negative
GOOGL Price Target Raise, SNPS Strong Guidance, LLY Retratrutide Results
featured
2026 Year for Small & Mid-Caps? Bull Case for Outperformance Against SPX
featured
Mesoblast (MESO) CEO on Stem Cell Therapies & Medical Pipeline
Bob Lang on Market Money Flows & Stock Picks: APO, BX, CG
featured
Mazza: 2026 Will Hold A.I. 'Winners and Losers,' Healthcare 'Super Underappreciated'
Why Biotech and Healthcare are Primed for AI
Sterner: 2025's Market Gives 2026 More Room for Bull Run
featured
Legend Biotech CEO (LEGN) on JNJ Partnership & Rapidly Scaling Cancer Drug Revenue
Labor Market Trends to Watch
featured
Madrigal Pharma (MDGL) CFO on Runaway Growth in Liver Disease Treatment
Dan Deming’s Stock Picks: GLW, CMI, DHR
Goldman: ‘Low Probability’ of a Santa Claus Rally in ‘Terrible Market Backdrop’
'Hard to get Bearish' in Current Market
BA Flies on Strong Commentary, WDC & STX Price Target Hikes, LLY Boost
Sam Miller on How to Determine AI Winners vs Losers
Michael Landsberg’s Picks: NEE, ENSG, ANET
Technical Tuesday: SPX, TMDX, TEM
